Sign in
4

Changes in Ownership

Spyre Therapeutics, Inc. Filed Acc 0001140361-17-045127

Director bought 17,121 shares at an average $4.86 ($83,177)

From the SEC's structured data for this filing

Trades in this filing

Quinn Anthony G. · Director

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2017-12-01 Purchase : show line 1 in the form +4,100 $4.53 $18,578 14,100 D
2017-12-04 Purchase : show line 2 in the form +7,956 $4.98 $39,624 22,056 D
2017-12-05 Purchase : show line 3 in the form +5,065 $4.93 $24,976 27,121 D
Open-market purchases · 17,121 sh · avg $4.86 · $83,177
Loading xslF345X03/doc1.xml…